1. Home
  2. ANVS vs LEE Comparison

ANVS vs LEE Comparison

Compare ANVS & LEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANVS
  • LEE
  • Stock Information
  • Founded
  • ANVS 2008
  • LEE 1890
  • Country
  • ANVS United States
  • LEE United States
  • Employees
  • ANVS N/A
  • LEE N/A
  • Industry
  • ANVS Biotechnology: Pharmaceutical Preparations
  • LEE Newspapers/Magazines
  • Sector
  • ANVS Health Care
  • LEE Consumer Discretionary
  • Exchange
  • ANVS Nasdaq
  • LEE Nasdaq
  • Market Cap
  • ANVS 44.6M
  • LEE 39.6M
  • IPO Year
  • ANVS 2020
  • LEE N/A
  • Fundamental
  • Price
  • ANVS $2.75
  • LEE $6.80
  • Analyst Decision
  • ANVS Strong Buy
  • LEE
  • Analyst Count
  • ANVS 4
  • LEE 0
  • Target Price
  • ANVS $18.00
  • LEE N/A
  • AVG Volume (30 Days)
  • ANVS 442.5K
  • LEE 34.0K
  • Earning Date
  • ANVS 08-14-2025
  • LEE 07-31-2025
  • Dividend Yield
  • ANVS N/A
  • LEE N/A
  • EPS Growth
  • ANVS N/A
  • LEE N/A
  • EPS
  • ANVS N/A
  • LEE N/A
  • Revenue
  • ANVS N/A
  • LEE $591,094,000.00
  • Revenue This Year
  • ANVS N/A
  • LEE N/A
  • Revenue Next Year
  • ANVS N/A
  • LEE N/A
  • P/E Ratio
  • ANVS N/A
  • LEE N/A
  • Revenue Growth
  • ANVS N/A
  • LEE N/A
  • 52 Week Low
  • ANVS $1.11
  • LEE $5.83
  • 52 Week High
  • ANVS $14.80
  • LEE $19.63
  • Technical
  • Relative Strength Index (RSI)
  • ANVS 57.81
  • LEE 54.12
  • Support Level
  • ANVS $2.24
  • LEE $6.04
  • Resistance Level
  • ANVS $2.97
  • LEE $7.00
  • Average True Range (ATR)
  • ANVS 0.26
  • LEE 0.37
  • MACD
  • ANVS 0.02
  • LEE 0.08
  • Stochastic Oscillator
  • ANVS 65.58
  • LEE 82.91

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

Share on Social Networks: